Immunology

(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
Zeile 2: Zeile 2:
  
 
'''Antibody-dependent enhancement'''
 
'''Antibody-dependent enhancement'''
−
 
+
{{ttp|p=32504046|t=2020. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.|pdf=|usr=007}}
 
{{ttp|p=32092539|t=2020. Is COVID-19 receiving ADE from other coronaviruses?|pdf=|usr=}}
 
{{ttp|p=32092539|t=2020. Is COVID-19 receiving ADE from other coronaviruses?|pdf=|usr=}}
 
{{tp|p=32268188|t=ä. It is too soon to attribute ADE to COVID-19 |pdf=|usr=}}
 
{{tp|p=32268188|t=ä. It is too soon to attribute ADE to COVID-19 |pdf=|usr=}}
Zeile 11: Zeile 11:
 
{{tp|p=32438257|t=2020. SARS-CoV-2 and enhancing antibodies |pdf=|usr=}}
 
{{tp|p=32438257|t=2020. SARS-CoV-2 and enhancing antibodies |pdf=|usr=}}
 
{{ttp|p=32408068|t=2020. What about the original antigenic sin of the humans versus SARS-CoV-2?|pdf=|usr=}}''the term «original antigenic sin» (OAS) was coined by T. Francis Jr at the Michigan University in the late 1950s to describe patterns of antibody response to influenza vaccination...''
 
{{ttp|p=32408068|t=2020. What about the original antigenic sin of the humans versus SARS-CoV-2?|pdf=|usr=}}''the term «original antigenic sin» (OAS) was coined by T. Francis Jr at the Michigan University in the late 1950s to describe patterns of antibody response to influenza vaccination...''
 +
{{tp|p=32436320|t=2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.|pdf=|usr=007}}
 +
{{tp|p=32506725|t=2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.|pdf=|usr=007}}
 +
 +
 +
'''Herd immunity'''
 +
{{tp|p=32438622|t=2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.|pdf=|usr=007}}
 +
{{tp|p=32391855|t=2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.|pdf=|usr=007}}
 +
{{tp|p=32510562|t=2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.|pdf=|usr=007}}
 +
{{tp|p=32418947|t=2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?|pdf=|usr=007}}
 +
{{tp|p=32372779|t=2020. Do you become immune once you have been infected?|pdf=|usr=}}
 +
 +
'''Neutralizing antibodies'''
 +
{{tp|p=32454513|t=2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.|pdf=|usr=007}}
 +
{{tp|p=32454512|t=2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.|pdf=|usr=007}}
 +
{{tp|p=32497196|t=2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.|pdf=|usr=007}}
 +
{{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and  binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}}
  
 
'''Innate sensing of infection'''
 
'''Innate sensing of infection'''
Zeile 19: Zeile 35:
 
{{tp|p=32248387|t=ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution |pdf=|usr=}}
 
{{tp|p=32248387|t=ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution |pdf=|usr=}}
 
{{ttp|p=32407669|t=ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients |pdf=|usr=}}
 
{{ttp|p=32407669|t=ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients |pdf=|usr=}}
 +
{{tp|p=32456409|t=2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.|pdf=|usr=007}}
 +
{{ttp|p=32156572|t=2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation |pdf=|usr=}}
  
 
'''nk cells'''
 
'''nk cells'''
 
{{tp|p=32382127|t=ä. NKG2A and COVID-19: another brick in the wall |pdf=|usr=}}
 
{{tp|p=32382127|t=ä. NKG2A and COVID-19: another brick in the wall |pdf=|usr=}}
 +
{{tp|p=32344314|t=2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents |pdf=|usr=}}
 +
  
 
'''integrative work'''
 
'''integrative work'''
Zeile 30: Zeile 50:
 
{{ttp|p=C7200337|t=ä. Immunology of COVID-19: current state of the science |pdf=|usr=}}
 
{{ttp|p=C7200337|t=ä. Immunology of COVID-19: current state of the science |pdf=|usr=}}
 
{{tp|p=32505227|t=2020. Immunology of COVID-19: Current State of the Science.|pdf=|usr=007}}
 
{{tp|p=32505227|t=2020. Immunology of COVID-19: Current State of the Science.|pdf=|usr=007}}
 +
{{tp|p=32469225|t=2020. COVID-19 and the immune system.|pdf=|usr=007}}
 +
{{ttp|p=32436629|t=2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.|pdf=|usr=007}}
 +
{{tp|p=32507543|t=2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.|pdf=|usr=007}}
 +
{{ttp|p=32504757|t=2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.|pdf=|usr=007}}
 +
{{tp|p=32493812|t=2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32470151|t=2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32472706|t=2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.|pdf=|usr=007}}
 +
{{tp|p=32213336|t=ä. SARS-CoV-2: virus dynamics and host response |pdf=|usr=}}
 +
  
 
'''covid modulates the immune system'''
 
'''covid modulates the immune system'''
Zeile 40: Zeile 69:
 
{{ttp|p=32236983|t=2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection |pdf=|usr=}}
 
{{ttp|p=32236983|t=2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection |pdf=|usr=}}
 
{{ttp|p=32286536|t=ä. Coronaviruses hijack the complement system |pdf=|usr=}}''host complement activator MASP2 as a target of the N protein of all three viruses''
 
{{ttp|p=32286536|t=ä. Coronaviruses hijack the complement system |pdf=|usr=}}''host complement activator MASP2 as a target of the N protein of all three viruses''
 +
{{tp|p=32463803|t=2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.|pdf=|usr=007}}
 +
{{tp|p=32492165|t=2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.|pdf=|usr=007}}
 +
  
 
'''mediators'''
 
'''mediators'''
Zeile 47: Zeile 79:
 
{{tp|p=30715745|t=2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study |pdf=|usr=}}
 
{{tp|p=30715745|t=2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study |pdf=|usr=}}
 
{{tp|p=32414693|t=2020. Interleukin-6 levels in children developing SARS-CoV-2 infection |pdf=|usr=}}
 
{{tp|p=32414693|t=2020. Interleukin-6 levels in children developing SARS-CoV-2 infection |pdf=|usr=}}
−
 
+
{{ttp|p=32421281|t=2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?|pdf=|usr=007}}
−
 
+
{{tp|p=32437622|t=2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.|pdf=|usr=007}}
  
 
'''plasmacytoid dendritic cells'''
 
'''plasmacytoid dendritic cells'''
Zeile 73: Zeile 105:
 
{{tp|p=32379199|t=2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes |pdf=|usr=}}
 
{{tp|p=32379199|t=2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes |pdf=|usr=}}
 
{{tp|p=32296069|t=2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study |pdf=|usr=}}
 
{{tp|p=32296069|t=2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study |pdf=|usr=}}
−
 
+
{{tp|p=32407057|t=2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.|pdf=|usr=007}}
 
{{tp|p=32297828|t=2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 |pdf=|usr=}}
 
{{tp|p=32297828|t=2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19 |pdf=|usr=}}
 
{{tp|p=32370466|t=2020.  Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19  |pdf=|usr=}}
 
{{tp|p=32370466|t=2020.  Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19  |pdf=|usr=}}
Zeile 80: Zeile 112:
 
{{tp|p=32361250|t=2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients |pdf=|usr=}}
 
{{tp|p=32361250|t=2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients |pdf=|usr=}}
 
{{ttp|p=32376308|t=2020. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis |pdf=|usr=}}
 
{{ttp|p=32376308|t=2020. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis |pdf=|usr=}}
 +
{{tp|p=32458561|t=2020. Lymphopenia in COVID-19: Therapeutic opportunities.|pdf=|usr=007}}
 +
{{tp|p=32420610|t=2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.|pdf=|usr=007}}
 +
{{tp|p=32470153|t=2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32474608|t=2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.|pdf=|usr=007}}
  
  
Zeile 104: Zeile 140:
 
{{tp|p=32303696|t=ä. Macrophages: a Trojan horse in COVID-19?|pdf=|usr=}}
 
{{tp|p=32303696|t=ä. Macrophages: a Trojan horse in COVID-19?|pdf=|usr=}}
 
{{ttp|p=32376901|t=ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages |pdf=|usr=}}
 
{{ttp|p=32376901|t=ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages |pdf=|usr=}}
 +
{{tp|p=32423059|t=2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32485101|t=2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.|pdf=|usr=007}}
 +
{{tp|p=32423917|t=2020. COVID-19 as an Acute Inflammatory Disease.|pdf=|usr=007}}
 +
{{ttp|p=32512289|t=2020. Neutralizing antibodies mediate virus-immune pathology of COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32398875|t=2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32391668|t=2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].|pdf=|usr=007}}
 +
{{ttp|p=32498376|t=2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.|pdf=|usr=007}}
 +
{{tp|p=32460357|t=2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.|pdf=|usr=007}}
  
  
Zeile 122: Zeile 166:
 
{{tp|p=32382126|t=ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients |pdf=|usr=}}
 
{{tp|p=32382126|t=ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients |pdf=|usr=}}
 
{{tp|p=32200654|t=2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus  Infection |pdf=|usr=}}
 
{{tp|p=32200654|t=2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus  Infection |pdf=|usr=}}
 +
{{tp|p=32476607|t=2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.|pdf=|usr=007}}
 +
{{tp|p=32449333|t=2020. (+)Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.|pdf=|usr=007}}
 +
{{tp|p=32430094|t=2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.|pdf=|usr=007}}
 +
{{tp|p=32467617|t=2020. Serum IgA, IgM, and IgG responses in COVID-19.|pdf=|usr=007}}
 +
{{ttp|p=32467616|t=2020. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells.|pdf=|usr=007}}
 +
{{ttp|p=32463434|t=2020. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.|pdf=|usr=007}}
  
 
'''secondary autoimmunity'''
 
'''secondary autoimmunity'''
Zeile 129: Zeile 179:
 
{{ttp|p=32314313|t=2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?|pdf=|usr=}}
 
{{ttp|p=32314313|t=2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?|pdf=|usr=}}
 
{{tp|p=32389543|t=ä. COVID-19 and molecular mimicry: The Columbus? egg?|pdf=|usr=}}
 
{{tp|p=32389543|t=ä. COVID-19 and molecular mimicry: The Columbus? egg?|pdf=|usr=}}
−
 
+
{{tp|p=32444414|t=2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.|pdf=|usr=007}}
  
  
Zeile 143: Zeile 193:
 
{{ttp|p=32315429|t=ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
 
{{ttp|p=32315429|t=ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
 
{{tp|p=32315421|t=ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
 
{{tp|p=32315421|t=ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
 +
{{tp|p=32390402|t=2020. SARS-CoV-2 and Eosinophilia.|pdf=|usr=007}}
  
−
'''Immunogenetics'''
+
 
−
{{tp|p=32303592|t=2020. Human leukocyte antigen susceptibility map for SARS-CoV-2 |pdf=|usr=}}
+
'''microbiome'''
−
{{tp|p=32343152|t=2020. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases |pdf=|usr=}}
+
{{tp|p=32497191|t=2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.|pdf=|usr=007}}
 +
{{ttp|p=32426999|t=2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.|pdf=|usr=007}}
  
  
 
===007===
 
===007===
−
 
+
'''some other papers'''
−
{{tp|p=32454497|t=2020. COVID-19 and Nasal Cytobrush Cytology.|pdf=|usr=007}}
+
−
{{tp|p=32437316|t=2020. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States.|pdf=|usr=007}}
+
−
{{tp|p=32412897|t=2020. Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.|pdf=|usr=007}}
+
−
{{tp|p=32476607|t=2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.|pdf=|usr=007}}
+
−
{{tp|p=32475230|t=2020. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.|pdf=|usr=007}}
+
−
{{tp|p=32471334|t=2020. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.|pdf=|usr=007}}
+
−
{{tp|p=32496247|t=2020. Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario.|pdf=|usr=007}}
+
−
{{tp|p=32393680|t=2020. Incomplete Kawasaki Disease in a Child with Covid-19.|pdf=|usr=007}}
+
−
{{tp|p=32423095|t=2020. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.|pdf=|usr=007}}
+
−
{{tp|p=32397174|t=2020. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.|pdf=|usr=007}}
+
−
{{tp|p=32463803|t=2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.|pdf=|usr=007}}
+
−
{{tp|p=32459663|t=2020. COVID-19, microangiopathy, hemostatic activation, and complement.|pdf=|usr=007}}
+
−
{{tp|p=32217834|t=2020. SARS-CoV-2: a storm is raging.|pdf=|usr=007}}
+
−
{{tp|p=32486469|t=2020. COVID-19 Related Coagulopathy: A Distinct Entity?|pdf=|usr=007}}
+
−
{{tp|p=32466577|t=2020. Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics.|pdf=|usr=007}}
+
−
{{tp|p=32422996|t=2020. Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site.|pdf=|usr=007}}
+
−
{{tp|p=32403217|t=2020. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.|pdf=|usr=007}}
+
−
{{tp|p=32492165|t=2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.|pdf=|usr=007}}
+
−
{{tp|p=32427582|t=2020. Clinical and pathological investigation of severe COVID-19 patients.|pdf=|usr=007}}
+
−
{{tp|p=32501293|t=2020. Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease.|pdf=|usr=007}}
+
−
{{tp|p=32492292|t=2020. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.|pdf=|usr=007}}
+
−
{{tp|p=32484232|t=2020. Radiologisk och histologisk bild for en okad forstaelse vid covid-19.|pdf=|usr=007}}
+
−
{{tp|p=32475810|t=2020. The role of biomarkers in diagnosis of COVID-19 - A systematic review.|pdf=|usr=007}}
+
−
{{tp|p=32471829|t=2020. Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses.|pdf=|usr=007}}
+
−
{{tp|p=32512290|t=2020. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32512491|t=2020. COVID-19-related complications and decompression illness share main features.: Could the SARS-CoV2-related complications rely on blood foaming?|pdf=|usr=007}}
+
−
{{tp|p=32499358|t=2020. Complete Genome Sequence of a SARS-CoV-2 Strain Isolated in Northern Germany.|pdf=|usr=007}}
+
−
{{tp|p=32401000|t=2020. First ultrastructural autoptic findings of SARS-Cov-2 in olfactory pathways and brainstem.|pdf=|usr=007}}
+
−
{{tp|p=32483236|t=2020. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.|pdf=|usr=007}}
+
−
{{tp|p=32512569|t=2020. COVID-19 Attacks the Kidney: Ultrastructural Evidence for the Presence of Virus in the Glomerular Epithelium.|pdf=|usr=007}}
+
−
{{tp|p=32418306|t=2020. Comment on Matricardi PM et al: The first, holistic immunological model of COVID-19: Implications for prevention, diagnosis, and public health measures.|pdf=|usr=007}}
+
−
{{tp|p=32462467|t=2020. Covid-19 and Kawasaki Disease: A Glimpse at the Past for a Predictable Future.|pdf=|usr=007}}
+
−
{{tp|p=32397896|t=2020. Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings.|pdf=|usr=007}}
+
−
{{tp|p=32437232|t=2020. Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.|pdf=|usr=007}}
+
−
{{tp|p=32469225|t=2020. COVID-19 and the immune system.|pdf=|usr=007}}
+
−
{{tp|p=32511245|t=2020. A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis.|pdf=|usr=007}}
+
−
{{tp|p=32437478|t=2020. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32449333|t=2020. Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.|pdf=|usr=007}}
+
−
{{tp|p=32439706|t=2020. Reply to Sanchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.|pdf=|usr=007}}
+
−
{{tp|p=32436320|t=2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.|pdf=|usr=007}}
+
−
{{tp|p=32428139|t=2020. Hematological changes in Covid-19 infections.|pdf=|usr=007}}
+
−
{{tp|p=32404436|t=2020. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.|pdf=|usr=007}}
+
−
{{tp|p=32507360|t=2020. Delirium, sleep, COVID-19 and melatonin.|pdf=|usr=007}}
+
−
{{tp|p=32436629|t=2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.|pdf=|usr=007}}
+
−
{{tp|p=32507543|t=2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32421281|t=2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?|pdf=|usr=007}}
+
−
{{tp|p=32496734|t=2020. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome.|pdf=|usr=007}}
+
−
{{tp|p=32438622|t=2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.|pdf=|usr=007}}
+
−
{{tp|p=32423059|t=2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.|pdf=|usr=007}}
+
−
{{tp|p=32422894|t=2020. A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?|pdf=|usr=007}}
+
−
{{tp|p=32482591|t=2020. Swine enteric alphacoronavirus (swine acute diarrhea syndrome coronavirus): An update three years after its discovery.|pdf=|usr=007}}
+
−
{{tp|p=32503352|t=2020. Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia.|pdf=|usr=007}}
+
−
{{tp|p=32485101|t=2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.|pdf=|usr=007}}
+
−
{{tp|p=32420946|t=2020. COVID-19 and food allergy in children.|pdf=|usr=007}}
+
−
{{tp|p=32430094|t=2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.|pdf=|usr=007}}
+
−
{{tp|p=32451547|t=2020. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort.|pdf=|usr=007}}
+
−
{{tp|p=32423917|t=2020. COVID-19 as an Acute Inflammatory Disease.|pdf=|usr=007}}
+
−
{{tp|p=32463092|t=2020. Multisystem Inflammatory Syndrome in Children during the COVID-19 pandemic: a case series.|pdf=|usr=007}}
+
−
{{tp|p=32441749|t=2020. COVID-19 Associated Pediatric Multi-System Inflammatory Syndrome.|pdf=|usr=007}}
+
−
{{tp|p=32478523|t=2020. Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV.|pdf=|usr=007}}
+
−
{{tp|p=32461321|t=2020. Porcine epidemic diarrhea virus deficient in RNA cap guanine-N-7 methylation is attenuated and induces higher type I and III interferon responses.|pdf=|usr=007}}
+
−
{{tp|p=32461317|t=2020. Porcine Deltacoronavirus nsp5 Cleaves DCP1A to Decrease Its Antiviral Ability.|pdf=|usr=007}}
+
−
{{tp|p=32434888|t=2020. Replication of SARS-CoV-2 in human respiratory epithelium.|pdf=|usr=007}}
+
−
{{tp|p=32404529|t=2020. Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.|pdf=|usr=007}}
+
−
{{tp|p=32391855|t=2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.|pdf=|usr=007}}
+
−
{{tp|p=32511692|t=2020. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32511676|t=2020. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.|pdf=|usr=007}}
+
−
{{tp|p=32511667|t=2020. SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease?|pdf=|usr=007}}
+
−
{{tp|p=32424314|t=2020. SARS-CoV-2 causes COVID-19-like disease in cynomolgus macaques.|pdf=|usr=007}}
+
−
{{tp|p=32504757|t=2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.|pdf=|usr=007}}
+
−
{{tp|p=32504754|t=2020. Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?|pdf=|usr=007}}
+
−
{{tp|p=32512289|t=2020. Neutralizing antibodies mediate virus-immune pathology of COVID-19.|pdf=|usr=007}}
+
−
{{tp|p=32505911|t=2020. Antibiotic consumption may be linked to exaggeration of COVID-19.|pdf=|usr=007}}
+
−
{{tp|p=32485313|t=2020. MDA5 should be detected in severe COVID-19 patients.|pdf=|usr=007}}
+
−
{{tp|p=32506536|t=2020. Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome.|pdf=|usr=007}}
+
−
{{tp|p=32490726|t=2020. Thromboinflammatory response in SARS-CoV-2 sepsis.|pdf=|usr=007}}
+
−
{{tp|p=32407057|t=2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.|pdf=|usr=007}}
+
−
{{tp|p=32407507|t=2020. Genomic epidemiology, evolution, and transmission dynamics of porcine deltacoronavirus.|pdf=|usr=007}}
+
−
{{tp|p=32437597|t=2020. Covid-19, Angiogenesis, and ARDS Endotypes.|pdf=|usr=007}}
+
−
{{tp|p=32437596|t=2020. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.|pdf=|usr=007}}
+
−
{{tp|p=32504046|t=2020. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.|pdf=|usr=007}}
+
−
{{tp|p=32405028|t=2020. Infection of bat and human intestinal organoids by SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32398875|t=2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.|pdf=|usr=007}}
+
−
{{tp|p=32454513|t=2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.|pdf=|usr=007}}
+
−
{{tp|p=32454512|t=2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32438371|t=2020. Structure of replicating SARS-CoV-2 polymerase.|pdf=|usr=007}}
+
−
{{tp|p=32408338|t=2020. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.|pdf=|usr=007}}
+
−
{{tp|p=32396922|t=2020. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32469258|t=2020. Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.|pdf=|usr=007}}
+
−
{{tp|p=32423291|t=2020. Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists.|pdf=|usr=007}}
+
−
{{tp|p=32510562|t=2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.|pdf=|usr=007}}
+
−
{{tp|p=32467454|t=2020. Covid-19 and Kawasaki Disease: An Etiology or Coincidental Infection?|pdf=|usr=007}}
+
−
{{tp|p=32492695|t=2020. Does the newly observed inflammatory syndrome in children demonstrate a link between uncontrolled neutrophil extracellular traps formation and COVID-19?|pdf=|usr=007}}
+
−
{{tp|p=32439816|t=2020. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children.|pdf=|usr=007}}
+
−
{{tp|p=32456506|t=2020. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.|pdf=|usr=007}}
+
−
{{tp|p=32397915|t=2020. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).|pdf=|usr=007}}
+
−
{{tp|p=32503918|t=2020. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.|pdf=|usr=007}}
+
−
{{tp|p=32401447|t=2020. Quels liens entre le SARS-CoV-2 et la maladie de Kawasaki ?|pdf=|usr=007}}
+
−
{{tp|p=32348061|t=2020. COVID-19, une maladie endotheliale ?|pdf=|usr=007}}
+
−
{{tp|p=32502331|t=2020. Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.|pdf=|usr=007}}
+
−
{{tp|p=32467379|t=2020. The search for a COVID-19 animal model.|pdf=|usr=007}}
+
−
{{tp|p=32299928|t=2020. From mice to monkeys, animals studied for coronavirus answers.|pdf=|usr=007}}
+
−
{{tp|p=32433216|t=2020. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Corona virus.|pdf=|usr=007}}
+
−
{{tp|p=32482825|t=2020. Testing animals for SARS-CoV-2.|pdf=|usr=007}}
+
−
{{tp|p=32490723|t=2020. Development of a TaqMan-probe-based multiplex real-time PCR for the simultaneous detection of emerging and reemerging swine coronaviruses.|pdf=|usr=007}}
+
 
{{tp|p=32496715|t=2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]|pdf=|usr=007}}
 
{{tp|p=32496715|t=2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]|pdf=|usr=007}}
−
{{tp|p=32391668|t=2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].|pdf=|usr=007}}
 
−
{{tp|p=32392945|t=2020. [Comparison of pathological changes and pathogenic mechanisms caused by H1N1 influenza virus, highly pathogenic H5N1 avian influenza virus, SARS-CoV, MERS-CoV and 2019-nCoV].|pdf=|usr=007}}
 
−
{{tp|p=32213267|t=2020. [Interpretation of pathological changes for "Guidelines for the Diagnosis and Treatment of COVID-19 by the National Health Commission (Trial Version 7) "].|pdf=|usr=007}}
 
−
{{tp|p=32486534|t=2020. [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].|pdf=|usr=007}}
 
−
{{tp|p=32241072|t=2020. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].|pdf=|usr=007}}
 
−
{{tp|p=32455515|t=2020. [Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].|pdf=|usr=007}}
 
−
 
−
{{tp|p=32444414|t=2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.|pdf=|usr=007}}
 
 
{{tp|p=32455617|t=2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.|pdf=|usr=007}}
 
{{tp|p=32455617|t=2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.|pdf=|usr=007}}
−
{{tp|p=32418947|t=2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?|pdf=|usr=007}}
 
−
{{tp|p=32493739|t=2020. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.|pdf=|usr=007}}
 
−
{{tp|p=32467125|t=2020. Morphology of COVID-19-affected cells in peripheral blood film.|pdf=|usr=007}}
 
−
{{tp|p=32453863|t=2020. COVID-19 and ABO blood group: another viewpoint.|pdf=|usr=007}}
 
−
{{tp|p=32453859|t=2020. Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients.|pdf=|usr=007}}
 
−
{{tp|p=32433784|t=2020. High-fluorescent lymphocytes are increased in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32420613|t=2020. Atypical lymphocytes in peripheral blood of patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32420610|t=2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.|pdf=|usr=007}}
 
−
{{tp|p=32462701|t=2020. Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology.|pdf=|usr=007}}
 
 
{{tp|p=32512133|t=2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.|pdf=|usr=007}}
 
{{tp|p=32512133|t=2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.|pdf=|usr=007}}
−
{{tp|p=32458561|t=2020. Lymphopenia in COVID-19: Therapeutic opportunities.|pdf=|usr=007}}
 
−
{{tp|p=32443810|t=2020. A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping.|pdf=|usr=007}}
 
−
{{tp|p=32498376|t=2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32393592|t=2020. Cytokine storm and the prospects for immunotherapy with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32493734|t=2020. New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.|pdf=|usr=007}}
 
−
{{tp|p=32511972|t=2020. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32511971|t=2020. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32508038|t=2020. Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia?|pdf=|usr=007}}
 
−
{{tp|p=32508022|t=2020. Acute lung injury in patients with COVID-19 infection.|pdf=|usr=007}}
 
−
{{tp|p=32490934|t=2020. Ultrasound-guided minimally invasive autopsies: A protocol for the study of pulmonary and systemic involvement of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32503659|t=2020. Body temperature correlates with mortality in COVID-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32503382|t=2020. Biomarkers associated with COVID-19 disease progression.|pdf=|usr=007}}
 
−
{{tp|p=32452762|t=2020. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.|pdf=|usr=007}}
 
−
{{tp|p=32428990|t=2020. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019.|pdf=|usr=007}}
 
−
{{tp|p=32384045|t=2020. Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.|pdf=|usr=007}}
 
−
{{tp|p=32459984|t=2020. SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020.|pdf=|usr=007}}
 
−
{{tp|p=32507410|t=2020. The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.|pdf=|usr=007}}
 
−
{{tp|p=32507608|t=2020. Hepatic consequences of COVID-19 infection. Lapping or biting?|pdf=|usr=007}}
 
−
{{tp|p=32427393|t=2020. Telomeres and COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32428379|t=2020. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.|pdf=|usr=007}}
 
−
{{tp|p=32505742|t=2020. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases.|pdf=|usr=007}}
 
−
{{tp|p=32443177|t=2020. Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy.|pdf=|usr=007}}
 
−
{{tp|p=32424945|t=2020. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32460357|t=2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.|pdf=|usr=007}}
 
 
{{tp|p=32512089|t=2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.|pdf=|usr=007}}
 
{{tp|p=32512089|t=2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.|pdf=|usr=007}}
 
{{tp|p=32470223|t=2020. COVID-19: Structural Predictions of Viral Success.|pdf=|usr=007}}
 
{{tp|p=32470223|t=2020. COVID-19: Structural Predictions of Viral Success.|pdf=|usr=007}}
−
{{tp|p=32441844|t=2020. Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32512386|t=2020. Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site.|pdf=|usr=007}}
 
−
{{tp|p=32410502|t=2020. First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations.|pdf=|usr=007}}
 
−
{{tp|p=32397951|t=2020. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets.|pdf=|usr=007}}
 
−
{{tp|p=32437018|t=2020. TMPRSS2: Potential Biomarker for COVID-19 Outcomes.|pdf=|usr=007}}
 
−
{{tp|p=32455505|t=2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.|pdf=|usr=007}}
 
−
{{tp|p=32508068|t=2020. Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32470153|t=2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32470148|t=2020. Serum KL-6 concentrations as a novel biomarker of severe COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32462705|t=2020. Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam.|pdf=|usr=007}}
 
−
{{tp|p=32458459|t=2020. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study.|pdf=|usr=007}}
 
−
{{tp|p=32479682|t=2020. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study.|pdf=|usr=007}}
 
 
{{tp|p=32423901|t=2020. How covid-19 is accelerating the threat of antimicrobial resistance.|pdf=|usr=007}}
 
{{tp|p=32423901|t=2020. How covid-19 is accelerating the threat of antimicrobial resistance.|pdf=|usr=007}}
−
{{tp|p=32414749|t=2020. Covid-19: Cases of inflammatory syndrome in children surge after urgent alert.|pdf=|usr=007}}
 
−
{{tp|p=32493704|t=2020. Pediatric inflammatory syndrome temporally related to covid-19.|pdf=|usr=007}}
 
−
{{tp|p=32420607|t=2020. The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants.|pdf=|usr=007}}
 
−
{{tp|p=32495372|t=2020. Terminal complement inhibition dampens the inflammation during COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32497257|t=2020. A lesson from a saboteur: high molecular weight kininogen (HMWK) impact in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32484220|t=2020. Discovery of G-quadruplex-forming sequences in SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32444466|t=2020. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.|pdf=|usr=007}}
 
−
{{tp|p=32412400|t=2020. Covid-19 and Kawasaki syndrome: should we really be surprised?|pdf=|usr=007}}
 
−
{{tp|p=32420587|t=2020. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction.|pdf=|usr=007}}
 
−
{{tp|p=32467617|t=2020. Serum IgA, IgM, and IgG responses in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32467616|t=2020. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells.|pdf=|usr=007}}
 
−
{{tp|p=32484450|t=2020. Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
 
−
{{tp|p=32504637|t=2020. Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator.|pdf=|usr=007}}
 
−
{{tp|p=32463434|t=2020. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.|pdf=|usr=007}}
 
−
{{tp|p=32445579|t=2020. Prognostic value of C-reactive protein in patients with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32497196|t=2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.|pdf=|usr=007}}
 
−
{{tp|p=32497191|t=2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.|pdf=|usr=007}}
 
−
{{tp|p=32390402|t=2020. SARS-CoV-2 and Eosinophilia.|pdf=|usr=007}}
 
−
{{tp|p=32414743|t=2020. Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32506725|t=2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.|pdf=|usr=007}}
 
−
{{tp|p=32488957|t=2020. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.|pdf=|usr=007}}
 
−
{{tp|p=32430459|t=2020. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.|pdf=|usr=007}}
 
−
{{tp|p=32418550|t=2020. Are Iranian Sulfur Mustard Gas-Exposed Survivors More Vulnerable to SARS-CoV-2? Some Similarity in Their Pathogenesis.|pdf=|usr=007}}
 
−
{{tp|p=32501877|t=2020. Kinetic patterns of liver enzyme elevation with COVID-19 in the USA.|pdf=|usr=007}}
 
−
{{tp|p=32460534|t=2020. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism.|pdf=|usr=007}}
 
−
{{tp|p=32412405|t=2020. Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation.|pdf=|usr=007}}
 
−
{{tp|p=32460624|t=2020. The amount of cytokine-release defines different shades of Sars-Cov2 infection.|pdf=|usr=007}}
 
−
{{tp|p=32472763|t=2020. Comparative analysis of Coronaviridae nucleocapsid and surface glycoprotein sequences.|pdf=|usr=007}}
 
−
{{tp|p=32393819|t=2020. COVID-19 outcomes and the human genome.|pdf=|usr=007}}
 
−
{{tp|p=32475052|t=2020. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.|pdf=|usr=007}}
 
−
{{tp|p=32404331|t=2020. COVID-19 and Kawasaki Disease: Finding the Signal in the Noise.|pdf=|usr=007}}
 
−
{{tp|p=32426999|t=2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.|pdf=|usr=007}}
 
−
{{tp|p=32503824|t=2020. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study.|pdf=|usr=007}}
 
−
{{tp|p=32503822|t=2020. Human Gene Sequences in SARS-CoV-2 and Other Viruses.|pdf=|usr=007}}
 
−
{{tp|p=32503821|t=2020. SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.|pdf=|usr=007}}
 
−
{{tp|p=32474554|t=2020. Mapping the genomic landscape & diversity of COVID-19 based on >3950 clinical isolates of SARS-CoV-2: Likely origin & transmission dynamics of isolates sequenced in India.|pdf=|usr=007}}
 
−
{{tp|p=32474553|t=2020. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.|pdf=|usr=007}}
 
−
{{tp|p=32462354|t=2020. Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32485332|t=2020. SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran.|pdf=|usr=007}}
 
−
{{tp|p=32468151|t=2020. The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?|pdf=|usr=007}}
 
−
{{tp|p=32468052|t=2020. Pancancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARSCoV2 infection leading to COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32456409|t=2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.|pdf=|usr=007}}
 
−
{{tp|p=32476380|t=2020. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.|pdf=|usr=007}}
 
−
{{tp|p=32490733|t=2020. Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans.|pdf=|usr=007}}
 
−
{{tp|p=32434769|t=2020. Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32401043|t=2020. Conserved High Free Energy Sites in Human Coronavirus Spike Glycoprotein Backbones.|pdf=|usr=007}}
 
−
{{tp|p=32493814|t=2020. Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32493812|t=2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32474608|t=2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.|pdf=|usr=007}}
 
−
{{tp|p=32433742|t=2020. Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus.|pdf=|usr=007}}
 
−
{{tp|p=32506640|t=2020. Viral Infections and Their Relationship with Catastrophic Antiphospholipid Syndrome: A Possible Pathogenic Mechanism of Severe COVID-19 Thrombotic Complications.|pdf=|usr=007}}
 
−
{{tp|p=32472706|t=2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.|pdf=|usr=007}}
 
−
{{tp|p=32470151|t=2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32497323|t=2020. Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection.|pdf=|usr=007}}
 
−
{{tp|p=32497295|t=2020. Comment on "Genetic variants and source of introduction of SARS-CoV-2 in South America".|pdf=|usr=007}}
 
−
{{tp|p=32492206|t=2020. Understanding the possible origin and genotyping of first Bangladeshi SARS-CoV-2 strain.|pdf=|usr=007}}
 
−
{{tp|p=32492203|t=2020. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.|pdf=|usr=007}}
 
−
{{tp|p=32492196|t=2020. High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing.|pdf=|usr=007}}
 
−
{{tp|p=32492195|t=2020. Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations.|pdf=|usr=007}}
 
−
{{tp|p=32492183|t=2020. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.|pdf=|usr=007}}
 
−
{{tp|p=32478897|t=2020. Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.|pdf=|usr=007}}
 
−
 
−
{{tp|p=32501810|t=2020. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.|pdf=|usr=007}}
 
−
{{tp|p=32484453|t=2020. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.|pdf=|usr=007}}
 
 
{{tp|p=32413176|t=2020. The emergence of methemoglobinemia amidst the COVID-19 pandemic.|pdf=|usr=007}}
 
{{tp|p=32413176|t=2020. The emergence of methemoglobinemia amidst the COVID-19 pandemic.|pdf=|usr=007}}
−
{{tp|p=32510973|t=2020. Decoding SARS-CoV-2 Hijacking of Host Mitochondria in Pathogenesis of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32469255|t=2020. SARS-CoV-2 perturbs the Renin-Angiotensin System and energy metabolism.|pdf=|usr=007}}
 
−
{{tp|p=32501731|t=2020. Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2?|pdf=|usr=007}}
 
−
{{tp|p=32493030|t=2020. Thoughts on the alveolar phase of COVID-19.|pdf=|usr=007}}
 
 
{{tp|p=32504123|t=2020. COVID-19 research: toxicological input urgently needed!|pdf=|usr=007}}
 
{{tp|p=32504123|t=2020. COVID-19 research: toxicological input urgently needed!|pdf=|usr=007}}
−
{{tp|p=32420944|t=2020. The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses.|pdf=|usr=007}}
 
−
{{tp|p=32420938|t=2020. What happens to people's lungs when they get coronavirus disease 2019?|pdf=|usr=007}}
 
−
{{tp|p=32506059|t=2020. Detection of Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage Fluid of COVID-19 Patients: Is Perls Stain a Potential Indicator of Oxidative Alveolar Damage?|pdf=|usr=007}}
 
−
{{tp|p=32496587|t=2020. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.|pdf=|usr=007}}
 
−
{{tp|p=32451533|t=2020. Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.|pdf=|usr=007}}
 
−
{{tp|p=32441303|t=2020. Placental Pathology in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32472588|t=2020. Increased sFLT1/PlGF ratio in COVID-19: a novel link to Angiotensin II-mediated endothelial dysfunction.|pdf=|usr=007}}
 
−
{{tp|p=32491212|t=2020. Circulating endothelial cells in COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32479159|t=2020. Related molecular mechanisms of COVID-19, hypertension, and diabetes.|pdf=|usr=007}}
 
−
{{tp|p=32437622|t=2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.|pdf=|usr=007}}
 
−
{{tp|p=32432483|t=2020. Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium.|pdf=|usr=007}}
 
 
{{tp|p=32412787|t=2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.|pdf=|usr=007}}
 
{{tp|p=32412787|t=2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.|pdf=|usr=007}}
−
{{tp|p=32410724|t=2020. The Lungs before and after COVID-19 Pneumonia.|pdf=|usr=007}}
 
−
{{tp|p=32422081|t=2020. Autopsy Report with Clinical Pathological Correlation.|pdf=|usr=007}}
 
−
{{tp|p=32510978|t=2020. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?|pdf=|usr=007}}
 
−
{{tp|p=32470119|t=2020. Coronavirus3D: 3D structural visualization of COVID-19 genomic divergence.|pdf=|usr=007}}
 
−
{{tp|p=32418446|t=2020. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic.|pdf=|usr=007}}
 
−
{{tp|p=32386190|t=2020. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis.|pdf=|usr=007}}
 
−
{{tp|p=32459190|t=2020. Low levels of total and ionized calcium in blood of COVID-19 patients.|pdf=|usr=007}}
 
−
{{tp|p=32441666|t=2020. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.|pdf=|usr=007}}
 
−
 
−
{{tp|p=32213336|t=ä. SARS-CoV-2: virus dynamics and host response |pdf=|usr=}}
 
 
{{tp|p=32213337|t=ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort  study |pdf=|usr=}}
 
{{tp|p=32213337|t=ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort  study |pdf=|usr=}}
−
{{tp|p=32344307|t=2020. COVID-19 type III hypersensitivity reaction |pdf=|usr=}}
 
−
{{tp|p=32344314|t=2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents |pdf=|usr=}}
 
−
 
−
 
−
'''some other papers'''
 
−
 
 
{{tp|p=32215589|t=2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia |pdf=|usr=}}
 
{{tp|p=32215589|t=2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia |pdf=|usr=}}
 
{{tp|p=32360743|t=ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19 |pdf=|usr=}}
 
{{tp|p=32360743|t=ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19 |pdf=|usr=}}
Zeile 419: Zeile 218:
 
{{tp|p=32346093|t=ä. The trinity of COVID-19: immunity, inflammation and intervention |pdf=|usr=}}
 
{{tp|p=32346093|t=ä. The trinity of COVID-19: immunity, inflammation and intervention |pdf=|usr=}}
 
{{tp|p=32348636|t=2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva |pdf=|usr=}}
 
{{tp|p=32348636|t=2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva |pdf=|usr=}}
−
{{tp|p=32297330|t=2020. Reactive lymphocytes in patients with Covid-19 |pdf=|usr=}}
 
−
{{tp|p=32311762|t=2020. SARS-CoV-2: a new aetiology for atypical lymphocytes |pdf=|usr=}}
 
−
{{ttp|p=32156572|t=2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation |pdf=|usr=}}
 
 
{{tp|p=32235915|t=ä. COVID-19: a new challenge for human beings |pdf=|usr=}}
 
{{tp|p=32235915|t=ä. COVID-19: a new challenge for human beings |pdf=|usr=}}
 
{{ttp|p=32359201|t=2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |pdf=|usr=}}
 
{{ttp|p=32359201|t=2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures |pdf=|usr=}}
−
{{ttp|p=32073157|t=2020. Antibodies to coronaviruses are higher in older compared with younger adults and  binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses |pdf=|usr=}}
 
 
{{tp|p=32376309|t=2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients |pdf=|usr=}}
 
{{tp|p=32376309|t=2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients |pdf=|usr=}}
 
{{tp|p=32132669|t=ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV |pdf=|usr=}}
 
{{tp|p=32132669|t=ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV |pdf=|usr=}}
 
{{tp|p=32388390|t=2020. The powerful immune system against powerful COVID-19: A hypothesis |pdf=|usr=}}
 
{{tp|p=32388390|t=2020. The powerful immune system against powerful COVID-19: A hypothesis |pdf=|usr=}}
 
{{tp|p=32372807|t=2020. The fever paradox |pdf=|usr=}}
 
{{tp|p=32372807|t=2020. The fever paradox |pdf=|usr=}}
−
{{tp|p=32372779|t=2020. Do you become immune once you have been infected?|pdf=|usr=}}
 

Version vom 23. Juni 2020, 11:48 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Antibody-dependent enhancement

32504046 2020. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.
32092539 2020. Is COVID-19 receiving ADE from other coronaviruses?


32268188 ä. It is too soon to attribute ADE to COVID-19

31826992 2020. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
antibodies target one serotype of viruses but only subneutralize another, leading to antibody-dependend enhancement of the latter viruses.
32317716 ä. The potential danger of suboptimal antibody responses in COVID-19
ade


32346094 ä. COVID-19 vaccine design: the Janus face of immune enhancement
32303697 ä. Will we see protection or reinfection in COVID-19?
32438257 2020. SARS-CoV-2 and enhancing antibodies

32408068 2020. What about the original antigenic sin of the humans versus SARS-CoV-2?
the term «original antigenic sin» (OAS) was coined by T. Francis Jr at the Michigan University in the late 1950s to describe patterns of antibody response to influenza vaccination...


32436320 2020. The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
32506725 2020. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.


Herd immunity
32438622 2020. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic.
32391855 2020. COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions.
32510562 2020. Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge.
32418947 2020. Does immune privilege result in recovered patients testing positive for COVID-19 again?
32372779 2020. Do you become immune once you have been infected?

Neutralizing antibodies
32454513 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection.
32454512 2020. A human neutralizing antibody targets the receptor binding site of SARS-CoV-2.
32497196 2020. Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients.

32073157 2020. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus?associated illnesses

Innate sensing of infection

32291557 ä. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells


32198201 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
32374430 2020. DC/L-SIGNs of Hope in the COVID-19 Pandemic
32361001 ä. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
32248387 ä. Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution

32407669 ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients


32456409 2020. A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.

32156572 2020. Viroporins and inflammasomes: A key to understand virus-induced inflammation

nk cells
32382127 ä. NKG2A and COVID-19: another brick in the wall
32344314 2020. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents


integrative work


32205856 2020. COVID-19 infection: the perspectives on immune responses
32359396 ä. A Dynamic Immune Response Shapes COVID-19 Progression
C7064018 ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

C7200337 ä. Immunology of COVID-19: current state of the science


32505227 2020. Immunology of COVID-19: Current State of the Science.
32469225 2020. COVID-19 and the immune system.

32436629 2020. High COVID-19 virus replication rates, the creation of antigen-antibody immune complexes and indirect haemagglutination resulting in thrombosis.


32507543 2020. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.

32504757 2020. Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.


32493812 2020. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
32470151 2020. The perplexing question of trained immunity versus adaptive memory in COVID-19.
32472706 2020. The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.
32213336 ä. SARS-CoV-2: virus dynamics and host response


covid modulates the immune system
32364527 2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
32172672 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China

32355328 ä. Impaired interferon signature in severe COVID-19


32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study
32376308 ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

32236983 2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection
32286536 ä. Coronaviruses hijack the complement system
host complement activator MASP2 as a target of the N protein of all three viruses


32463803 2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
32492165 2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.


mediators
32360285 ä. Type I IFN immunoprofiling in COVID-19 patients

32376393 ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
32305501 ä. The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement


30715745 2019. (+)Th17 serum cytokines in relation to laboratory?confirmed respiratory viral infection: A pilot study
32414693 2020. Interleukin-6 levels in children developing SARS-CoV-2 infection

32421281 2020. Is there relationship between SARS-CoV 2 and the complement C3 and C4?


32437622 2020. Complement Activation During Critical Illness: Current Findings and an Outlook in the Era of COVID-19.

plasmacytoid dendritic cells
32298486 2020. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)

immune cell subpopulations
32282871 ä. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)
32325421 2020. Increased expression of CD8 marker on T-cells in COVID-19 patients
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32346099 ä. High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
32339487 2020. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
32228226 2020. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients
32196410 2020. Hypothesis for potential pathogenesis of SARS-CoV-2 infection?a review of immune changes in patients with viral pneumonia
32333914 ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia
32344320 ä. The clinical course and its correlated immune status in COVID-19 pneumonia
32325129 ä. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia
32283159 ä. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
32227123 ä. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
32343510 2020. COVID-19: are T lymphocytes simply watching?
32379887 ä. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19
32297671 2020. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
32352397 2020. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
32379199 2020. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes
32296069 2020. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
32407057 2020. Peripheral lymphocyte subset monitoring in COVID19 patients: a prospective Italian real-life case series.
32297828 2020. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19
32370466 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32114745 2020. Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19
32377375 2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
32361250 2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients

32376308 2020. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis


32458561 2020. Lymphopenia in COVID-19: Therapeutic opportunities.
32420610 2020. Temporal changes in immune blood cell parameters in COVID-19 infection and recovery from severe infection.
32470153 2020. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
32474608 2020. Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study.


t cell exhaustion
32249845 ä. Fighting COVID-19 exhausts T cells

32203188 ä. Functional exhaustion of antiviral lymphocytes in COVID-19 patients
32203186 ä. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
32203188 2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients
32203186 2020. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients


immunopathology
32371101 ä. The correlation between SARS-CoV-2 infection and rheumatic disease
32205186 2020. COVID-19 infection and rheumatoid arthritis: Faraway, so close!
32308263 2020. CoViD-19 Immunopathology and Immunotherapy
32320677 ä. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
32161940 ä. Dysregulation of immune response in patients with COVID-19 in Wuhan, China
32282863 ä. Molecular immune pathogenesis and diagnosis of COVID-19
32321823 2020. COVID-19: an Immunopathological View
32273594 ä. COVID-19: immunopathology and its implications for therapy
32303696 ä. Macrophages: a Trojan horse in COVID-19?

32376901 ä. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages


32423059 2020. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19.
32485101 2020. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
32423917 2020. COVID-19 as an Acute Inflammatory Disease.

32512289 2020. Neutralizing antibodies mediate virus-immune pathology of COVID-19.


32398875 2020. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.
32391668 2020. [Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].

32498376 2020. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19.


32460357 2020. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.


antiviral immune response
32280952 ä. Good IgA bad IgG in SARS-CoV-2 infection?
32353870 2020. The many faces of the anti-COVID immune response
32358956 ä. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19
31981224 2020. Coronavirus infections and immune responses
32198005 2020. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic
32284614 ä. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
32355329 ä. SARS-CoV-2-reactive T cells in patients and healthy donors
32346091 ä. Neutralizing antibody response in mild COVID-19
32356908 2020. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis

32343415 2020. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients


32330332 2020. SARS-CoV-2 infection in children - Understanding the immune responses and controlling the pandemic
32267987 2020. Immune responses and pathogenesis of SARS?CoV?2 during an outbreak in Iran: Comparison with SARS and MERS
32348715 2020. B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
32382126 ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients
32200654 2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection
32476607 2020. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.
32449333 2020. (+)Ability of the immune system to fight viruses highlighted by cytometry and TCR clonotype assessments: lessons taken prior to COVID-19 virus pandemic outbreak.
32430094 2020. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
32467617 2020. Serum IgA, IgM, and IgG responses in COVID-19.

32467616 2020. More bricks in the wall against SARS-CoV-2 infection: involvement of gamma9delta2 T cells.
32463434 2020. Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling.

secondary autoimmunity
32292901 2020. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity
32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32315487 2020. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19

32314313 2020. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?


32389543 ä. COVID-19 and molecular mimicry: The Columbus? egg?
32444414 2020. Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.


Thymus
32340873 ä. Reply: Thymopoiesis, inflamm-aging, and COVID-19 phenotype
32317217 ä. Role of thymopoiesis and inflamm-aging in COVID-19 phenotype


Eosinopenia, Eosinophilia
32368728 ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study
32344056 ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination
32369190 2020. COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series

32315429 ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19)


32315421 ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19)
32390402 2020. SARS-CoV-2 and Eosinophilia.


microbiome
32497191 2020. Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza.

32426999 2020. Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2, the Receptor for SARS-CoV-2 Infectivity.


007

some other papers
32496715 2020. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]
32455617 2020. Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique.
32512133 2020. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: A retrospective cohort study.
32512089 2020. Corona virus versus existence of human on the earth: A computational and biophysical approach.
32470223 2020. COVID-19: Structural Predictions of Viral Success.
32423901 2020. How covid-19 is accelerating the threat of antimicrobial resistance.
32413176 2020. The emergence of methemoglobinemia amidst the COVID-19 pandemic.
32504123 2020. COVID-19 research: toxicological input urgently needed!
32412787 2020. Bronchoscopy in COVID-19 Patients with Invasive Mechanical Ventilation: A Center Experience.
32213337 ä. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
32215589 2020. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
32360743 ä. Lower detection rates of SARS-COV2 antibodies in cancer patients vs healthcare workers after symptomatic COVID-19
32292530 2020. Respiratory diseases, allergy and COVID-19 infection. First news from Wuhan
32346093 ä. The trinity of COVID-19: immunity, inflammation and intervention
32348636 2020. Hyposalivation as a potential risk for SARS-CoV-2 infection: Inhibitory role of saliva
32235915 ä. COVID-19: a new challenge for human beings

32359201 2020. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures


32376309 2020. Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients
32132669 ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV
32388390 2020. The powerful immune system against powerful COVID-19: A hypothesis
32372807 2020. The fever paradox

Von „http://coviki.org/cov/index.php?title=Immunology&oldid=2970“
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis